a great 4d in #Munich with @myesmo.bsky.social. Spoke on the importance of sex after cancer & chaired a session on Breast Cancer in Young Women. With @tanjaspanic.bsky.social from #Slovenia my pal Matteo Lambertini from #Italy, Prof Inez Vaz-Luis from #France, and Antigoni Kretsi from #Greece
18.05.2025 12:07 — 👍 9 🔁 2 💬 2 📌 0
Thank you @tanjaspanic.bsky.social for speaking about "Patient perspective – what do WE really need?" at #SGBCC2025. The BIG Patient Partnership ensures that patient voice is heard at the early stage of research development & at every stage of BIG clinical trials.
17.03.2025 08:29 — 👍 2 🔁 2 💬 0 📌 0
Tanja Spanic
We had the opportunity to catch up with @tanjaspanic.bsky.social at #SGBCC2025, where she talked on tailoring therapies for early #breastcancer, and importance of survivorship and patient advocacy!
Visit VJOncology.com for exclusive interviews and more!
#bcsm
13.03.2025 14:51 — 👍 2 🔁 1 💬 0 📌 0
OncoAlert🚨Network with our partners at ESSO, ESGO, MASCC & SIOG invite you to the #OncoAlertColloquium
NEXT WEEK!!
FREE REGISTRATION HERE👉 buff.ly/3CChgre
February 3-9, 2025 💯% Virtual & Interactive
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@drjnaidoo.bsky.social
@hoperugo.bsky.social
29.01.2025 15:37 — 👍 5 🔁 4 💬 1 📌 1
United in our goals - equity of access for all our patients #WorldCancerDay2025 @oncoalert.bsky.social
04.02.2025 20:32 — 👍 9 🔁 1 💬 0 📌 0
To build on the progress shared at #SABCS24 for triple-positive MBC ( #PATINA), when treatments stop working, is it the HER2 or HR component driving resistance? Need a biomarker! Patients want the most mileage from every treatment!
PS: Finally, +++ is being treated differently from HER2+/HR–.
13.12.2024 23:40 — 👍 13 🔁 5 💬 1 📌 0
#SABCS24 #bcsm #OncSky
We need to ask all patients on endocrine therapy for #breastcancer about vaginal dryness & sexual dysfunction. Here’s a useful stepwise approach to managing these issues from
@JenniShengMD. #MedSky
@oncoalert.bsky.social
10.12.2024 23:53 — 👍 29 🔁 15 💬 2 📌 2
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Nonprofit 501(c)(3) dedicated to providing up-to-date breast cancer information and free support resources for people impacted by breast cancer.
Father and Husband, Oncologist, Editor, Writer, Academician, Humanist
Breast Oncologist and translational researcher @nki, Immunotherapy and immune cell lover, Mother, 🍀🌿
Professional Speaker - Author - Breast Surgeon with Breast Cancer
www.liz.oriordan.co.uk
She/Her. Living w #MBC since '13 & advocating for people w MBC to LIVE. #AntiRacist #InclusionPledge. Co-founder of @graspcancer.bsky.social & @therightdose.bsky.social. 🇧🇷🇺🇸🇩🇪
MBC advocate and patient, microbiologist, educator, nature lover, gardener, reader, and feminist. She/her/hers.
Ein Mensch. Ein Wort.
https://www.gruene.de/service/impressum
Nobody knows politics and policy like we do.
Breast Medical Oncologist, Advanced Fellow Dana-Farber | Harvard | PhD Unimi. SoMe Editor ESMO Open. Interested in breast oncology, HER2, ADCs and good music.
Early Phase Drug Development; Oncologist; Precision Medicine; Phase 1 trials; AI & Precision Oncology; Clinical trials. Posts=My own
Physician. Scientist. Dad. Breast Cancer Researcher. Thinking about and caring for the future. Striving for wisdom.
Medical Oncologist at Ziekenhuis Aan de Stroom Antwerp🇧🇪
Mission to improve outcome of patients with breast cancer #bcsm 🧬 #TNBC #BCY #HereditaryCancer @myBSMO @myESMO @EORTC_BCG
We’re the Breast Cancer Research Foundation, the highest-rated breast cancer research nonprofit in the U.S.
bcrf.org
Clinical Oncologist from Texas🇺🇸 @oncoalert.bsky.social Representative 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏
Cancer Center Director @hospitalclinic, CoFounder @RevealGenomics, TranslGenomics @IDIBAPS, Prof @UniBarcelona, Team @IOBoncologia, COI http://bit.ly/2Bdtd71
Patient-centered care, clinical trials & translational research on breast cancer @danafarber.bsky.social and Harvard Medical School.
Appts: 877-442-3324, Clinical trials: 877-338-7425
A leading European centre in personalized oncology, VHIO transforms lab discoveries into clinical breakthroughs through multidisciplinary research and global collaboration.
🌐 vhio.net
